6 results
S-1
EX-2.1
NMRA
Neumora Therapeutics Inc.
25 Aug 23
IPO registration
5:03pm
, including antitrust statutes relating to submission of offers, in any material respect.
3.21 Corporate Documents. The Company Certificate and bylaws
S-1
EX-10.4
NMRA
Neumora Therapeutics Inc.
25 Aug 23
IPO registration
5:03pm
and/or in a position to influence a purchasing decision of an Amgen Therapeutic Product.
Section 1.58 “HSR Act” means the Hart-Scott-Rodino Antitrust … under or relating to the HSR Act, and HSR Filing or any applicable foreign antitrust or competition-related legal requirement. AMGEN and RBNC shall
S-1
EX-10.3
NMRA
Neumora Therapeutics Inc.
25 Aug 23
IPO registration
5:03pm
-Rodino Antitrust Improvements Act of 1976 (15 U.S.C. § 18a).
Section 1.58 “HSR Filing” means a filing by each of Amgen and RBNC with the United States … , and HSR Filing or any applicable foreign antitrust or competition-related legal requirement. AMGEN and RBNC shall cooperate fully with each other
S-1
EX-10.2
NMRA
Neumora Therapeutics Inc.
25 Aug 23
IPO registration
5:03pm
national, state, county, city or other political subdivision.
Section 1.55 “HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976 … in connection with proceedings under or relating to the HSR Act, and HSR Filing or any applicable foreign antitrust or competition-related legal requirement
S-1
EX-2.2
tkkosy0bhvb7t6ku5tie
25 Aug 23
IPO registration
5:03pm
- Prev
- 1
- Next